Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-24

Clinical Trial Update: A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing three starting points for initiating antiretroviral therapy in HIV/Tuberculosis co-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: HIV Infections, Tuberculosis | Phase 3 | Status: COMPLETED